We're delighted to share that the International Journal of Neuropsychopharmacology has achieved an increased Impact Factor in the latest Journal Citation Reports release.

This growth reflects more than citations alone: readership, article usage, and engagement across the neuropsychopharmacology community demonstrate that research published in IJNP is being discovered, read, and used by scientists around the world.

We are particularly proud that our Impact Factor remains very close to the metric calculated without journal self-citations, highlighting that IJNP's influence is driven by the broader research community and reflecting genuine reach, relevance, and scientific impact. We extend our congratulations to the past editorial board team for this achievement.

Consider IJNP as the home for your next paper, and explore our Special Collections for opportunities to contribute to focused, high-impact areas of research.

Visit IJNP Website

The CINP 2026 - 37th World Congress of Neuropsychopharmacology, Glasgow, United Kingdom 26/06/2026 - 29/06/2026, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 19.5 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Professor Shigeto Yamawaki, former CINP President (2014–2016), passed away on June 8, 2026.

He made extraordinary contributions to neuropsychopharmacology, biological psychiatry, international scientific collaboration, and the development of CINP.

His passing is a great loss not only to Japan and Asia but also to the worldwide neuropsychopharmacology community.

We extend our heartfelt condolences to his family, friends, colleagues, and trainees.

Read the Obituary